Logo image of DTCK

DAVIS COMMODITIES LTD (DTCK) Stock Fundamental Analysis

NASDAQ:DTCK - Nasdaq - KYG2677P1054 - Common Stock

1.0801  -0.02 (-1.81%)

Fundamental Rating

5

DTCK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 41 industry peers in the Consumer Staples Distribution & Retail industry. DTCK has an excellent financial health rating, but there are some minor concerns on its profitability. DTCK has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

DTCK had positive earnings in the past year.
In the past year DTCK had a positive cash flow from operations.
DTCK Yearly Net Income VS EBIT VS OCF VS FCFDTCK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M 4M

1.2 Ratios

With an excellent Return On Assets value of 8.43%, DTCK belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
DTCK has a Return On Equity of 20.88%. This is in the better half of the industry: DTCK outperforms 77.50% of its industry peers.
DTCK has a better Return On Invested Capital (16.41%) than 97.50% of its industry peers.
DTCK had an Average Return On Invested Capital over the past 3 years of 88.94%. This is significantly above the industry average of 8.38%.
The 3 year average ROIC (88.94%) for DTCK is well above the current ROIC(16.41%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 8.43%
ROE 20.88%
ROIC 16.41%
ROA(3y)16.13%
ROA(5y)N/A
ROE(3y)104.73%
ROE(5y)N/A
ROIC(3y)88.94%
ROIC(5y)N/A
DTCK Yearly ROA, ROE, ROICDTCK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 50 100 150 200

1.3 Margins

With a Profit Margin value of 0.94%, DTCK perfoms like the industry average, outperforming 47.50% of the companies in the same industry.
In the last couple of years the Profit Margin of DTCK has grown nicely.
With a Operating Margin value of 0.88%, DTCK is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
With a Gross Margin value of 3.86%, DTCK is not doing good in the industry: 97.50% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of DTCK has declined.
Industry RankSector Rank
OM 0.88%
PM (TTM) 0.94%
GM 3.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y14.44%
PM growth 5YN/A
GM growth 3Y-6.32%
GM growth 5YN/A
DTCK Yearly Profit, Operating, Gross MarginsDTCK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 2 4 6

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DTCK is creating value.
DTCK has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, DTCK has an improved debt to assets ratio.
DTCK Yearly Shares OutstandingDTCK Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M
DTCK Yearly Total Debt VS Total AssetsDTCK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 10.81 indicates that DTCK is not in any danger for bankruptcy at the moment.
DTCK has a better Altman-Z score (10.81) than 100.00% of its industry peers.
DTCK has a debt to FCF ratio of 0.27. This is a very positive value and a sign of high solvency as it would only need 0.27 years to pay back of all of its debts.
DTCK has a better Debt to FCF ratio (0.27) than 92.50% of its industry peers.
DTCK has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
DTCK's Debt to Equity ratio of 0.03 is amongst the best of the industry. DTCK outperforms 82.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.27
Altman-Z 10.81
ROIC/WACC1.8
WACC9.11%
DTCK Yearly LT Debt VS Equity VS FCFDTCK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M 6M 8M 10M

2.3 Liquidity

DTCK has a Current Ratio of 1.31. This is a normal value and indicates that DTCK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.31, DTCK is in the better half of the industry, outperforming 67.50% of the companies in the same industry.
DTCK has a Quick Ratio of 1.31. This is a bad value and indicates that DTCK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DTCK (0.93) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.93
DTCK Yearly Current Assets VS Current LiabilitesDTCK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

DTCK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -63.89%.
Measured over the past years, DTCK shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.38% on average per year.
The Revenue for DTCK has decreased by -15.40% in the past year. This is quite bad
DTCK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.17% yearly.
EPS 1Y (TTM)-63.89%
EPS 3Y30.38%
EPS 5YN/A
EPS Q2Q%-35.11%
Revenue 1Y (TTM)-15.4%
Revenue growth 3Y13.17%
Revenue growth 5YN/A
Sales Q2Q%-31.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DTCK Yearly Revenue VS EstimatesDTCK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 50M 100M 150M 200M
DTCK Yearly EPS VS EstimatesDTCK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

DTCK is valuated reasonably with a Price/Earnings ratio of 10.80.
87.50% of the companies in the same industry are more expensive than DTCK, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.29, DTCK is valued rather cheaply.
Industry RankSector Rank
PE 10.8
Fwd PE N/A
DTCK Price Earnings VS Forward Price EarningsDTCK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

DTCK's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, DTCK is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.35
EV/EBITDA 11.08
DTCK Per share dataDTCK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DTCK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DAVIS COMMODITIES LTD

NASDAQ:DTCK (1/22/2025, 10:59:40 AM)

1.0801

-0.02 (-1.81%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.18%
Inst Owner ChangeN/A
Ins Owners37.27%
Ins Owner ChangeN/A
Market Cap26.46M
AnalystsN/A
Price TargetN/A
Short Float %6.85%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.8
Fwd PE N/A
P/S 0.1
P/FCF 13.35
P/OCF 13.34
P/B 2.28
P/tB 2.28
EV/EBITDA 11.08
EPS(TTM)0.1
EY9.26%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.08
FCFY7.49%
OCF(TTM)0.08
OCFY7.5%
SpS10.51
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.43%
ROE 20.88%
ROCE 19.13%
ROIC 16.41%
ROICexc 18.53%
ROICexgc 18.53%
OM 0.88%
PM (TTM) 0.94%
GM 3.86%
FCFM 0.77%
ROA(3y)16.13%
ROA(5y)N/A
ROE(3y)104.73%
ROE(5y)N/A
ROIC(3y)88.94%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)103.68%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y14.44%
PM growth 5YN/A
GM growth 3Y-6.32%
GM growth 5YN/A
F-Score3
Asset Turnover8.97
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.27
Debt/EBITDA 0.13
Cap/Depr 2.5%
Cap/Sales 0%
Interest Coverage 36.17
Cash Conversion 84.1%
Profit Quality 81.9%
Current Ratio 1.31
Quick Ratio 0.93
Altman-Z 10.81
F-Score3
WACC9.11%
ROIC/WACC1.8
Cap/Depr(3y)171.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.89%
EPS 3Y30.38%
EPS 5YN/A
EPS Q2Q%-35.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.4%
Revenue growth 3Y13.17%
Revenue growth 5YN/A
Sales Q2Q%-31.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.15%
FCF growth 3Y-19.86%
FCF growth 5YN/A
OCF growth 1Y48.06%
OCF growth 3Y-14.95%
OCF growth 5YN/A